BmemHLA : Origins of the Heterogeneity of the Anti-HLA Memory B Cells in Kidney Transplantation

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Bordeaux

About this trial

This study will describe the transcriptomic and phenotypic characteristics of anti-HLA memory B cells by comparing five groups of patients awaiting renal transplantation: patients with a single history of pregnancy, transfusion or failure of a first renal transplant requiring transplantectomy within 3 months of transplantation, or after 3 months, and patients without an immunizing allogeneic event. The hypothesis is that these five contexts induce different types of memory B cells with different modalities of reactivation and post-transplant pathogenicity.

Eligibility criteria

Qualifiers

Adult kidney transplantation candidate at CHU de Bordeaux

Sensitized against class I HLA

Only on type of sensitizing event among : transfusion, pregnancy, previous transplantation, no senitizing event

Disqualifiers

Pediatric kidney transplantation candidate at CHU de Bordeaux

Rituximab injection

Ongoing treatment with immunosuppressive drugs

Non-cutaneous carcinoma, chronic viral infection

Trial design

Treatments tested in this trial

  • Identification of types of anti-HLA-specific memory LBs

Treatment groups

75 Participants
are divided into 5 treatment groups

Locations

This trial has no locations

Sponsors and collaborators